Search

everythinglearnresearchcommunity

for

Search:↓

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Platelet-rich plasma can potentially promote hair growth by stimulating cell growth and increasing certain proteins.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Spironolactone most effective for hirsutism, but has side effects.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Vervet monkeys show physical changes like hair loss and scrotal color changes due to stress or nutrition issues.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Women with thinning hair have thinner hair strands than women without hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Melatonin affects mouse skin and may regulate skin functions.